Pages that link to "Q38174265"

The following pages link to New therapeutic perspectives in HBV: when to stop NAs. (Q38174265):

Displaying 12 items.

• DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus (Q28552967) (← links)
• Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance. (Q34289969) (← links)
• Effects of interleukin 10 polymorphisms on the development of hepatitis B virus infection: a systemic review and meta-analysis (Q36182597) (← links)
• Chronic hepatitis B virus in young adults: the need for new approaches to management (Q38232829) (← links)
• Prevention of hepatitis B virus infection: from the past to the future (Q38354222) (← links)
• Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model (Q38559455) (← links)
• New paradigms in hepatitis B management: only diamonds are forever (Q38588187) (← links)
• Monotherapy for hepatitis B infection: a review of treatment options (Q38594605) (← links)
• An update on the strategies used for the treatment of chronic hepatitis B in children. (Q38692198) (← links)
• DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy. (Q39127382) (← links)
• The role of peginterferon in nucleos(t)ide-analogue-treated chronic hepatitis B patients: A review of published literature (Q39140348) (← links)
• Antiviral Therapy in Chronic Hepatitis B With Mild Acute Exacerbation (Q40303523) (← links)